Cantitate/Preț
Produs

Minimal Residual Disease Testing: Current Innovations and Future Directions

Editat de Todd E. Druley
en Limba Engleză Paperback – 27 noi 2018
This volume provides a concise yet comprehensive overview of minimal residual disease (MRD) testing. The text reviews the history of MRD testing, MRD testing for acute lymphoblastic leukemia/lymphoma, molecular diagnostics for MRD analysis in hematopoietic malignancies, the use of "difference from normal" flow cytometry in monitoring AML response, ML-DS for measurable residual disease detection, and advancements in next generation sequencing for detecting MRD. 
Written by experts in the field, Minimal Residual Disease Testing: Current Innovations and Future Directions is a valuable resource for hematologists, oncologists, pathologists, and radiologists on the variety of technologies available to detect MRD and how best to integrate these platforms into clinical practice.

Citește tot Restrânge

Preț: 46792 lei

Preț vechi: 49254 lei
-5% Nou

Puncte Express: 702

Preț estimativ în valută:
8955 9302$ 7438£

Carte tipărită la comandă

Livrare economică 31 ianuarie-06 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319948263
ISBN-10: 3319948261
Pagini: 158
Ilustrații: VIII, 197 p. 28 illus., 27 illus. in color.
Dimensiuni: 127 x 203 mm
Greutate: 0.45 kg
Ediția:1st ed. 2019
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland

Cuprins

Introduction.- Minimal Residual Disease Testing in Acute Lymphoblastic Leukemia/Lymphoma.- Molecular Diagnostics for Minimal Residual Disease Analysis in Hematopoietic Malignancies.- Monitoring AML Response Using “Difference From Normal” Flow Cytometry.- ML-DS: A Unique Condition for Measurable Residual Disease Detection.- Advancements in Next Generation Sequencing for Detecting Minimal Residual Disease.

Notă biografică

Todd E. Druley, MD, PhD
Associate Professor of Pediatrics, Genetics and Developmental Biology
Director, Fellowship Program in Pediatric Hematology and Oncology
Director, Pediatric Cancer Predisposition Program
Washington University in St. Louis
Department of Pediatrics
Division of Hematology and Oncology
Center for Genome Sciences and Systems Biology
St. Louis, MO 
USA

Textul de pe ultima copertă

This volume provides a concise yet comprehensive overview of minimal residual disease (MRD) testing. The text reviews the history of MRD testing, MRD testing for acute lymphoblastic leukemia/lymphoma, molecular diagnostics for MRD analysis in hematopoietic malignancies, the use of "difference from normal" flow cytometry in monitoring AML response, ML-DS for measurable residual disease detection, and advancements in next generation sequencing for detecting MRD.
Written by experts in the field, Minimal Residual Disease Testing: Current Innovations and Future Directions is a valuable resource for hematologists, oncologists, pathologists, and radiologists on the variety of technologies available to detect MRD and how best to integrate these platforms into clinical practice.

Caracteristici

Provides a concise yet comprehensive overview on all aspects of minimal residual disease testing Presented in an easy-to-read format Written by experts in the field